Comment
doi: 10.1161/CIRCULATIONAHA.115.020948.
Response to the Letter Regarding Article, "Bringing Back Targets to 'IMPROVE' Atherosclerotic Cardiovascular Disease Outcomes: The Duel for Dual Goals; Are Two Targets Better Than One?"
Affiliations
- PMID: 27022049
- DOI: 10.1161/CIRCULATIONAHA.115.020948
Item in Clipboard
Comment
Response to the Letter Regarding Article, "Bringing Back Targets to 'IMPROVE' Atherosclerotic Cardiovascular Disease Outcomes: The Duel for Dual Goals; Are Two Targets Better Than One?"
Circulation.
.
No abstract available
Comment on
-
Bringing back targets to "IMPROVE" atherosclerotic cardiovascular disease outcomes: the duel for dual goals; are two targets better than one?Circulation. 2015 Sep 29;132(13):1218-20. doi: 10.1161/CIRCULATIONAHA.115.018511. Epub 2015 Sep 1. Circulation. 2015. PMID: 26330413 No abstract available.
-
Letter by Robinson Regarding Articles, "Bringing Back Targets to 'IMPROVE' Atherosclerotic Cardiovascular Disease Outcomes: The Duel for Dual Goals; Are Two Targets Better Than One?" and "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT".Circulation. 2016 Mar 29;133(13):e461. doi: 10.1161/CIRCULATIONAHA.115.019345. Circulation. 2016. PMID: 27022048 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
